4//SEC Filing
Gordon Joseph F 4
Accession 0000899243-22-008830
CIK 0000885590other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 9:29 PM ET
Size
16.7 KB
Accession
0000899243-22-008830
Insider Transaction Report
Form 4
Gordon Joseph F
President Bausch & Lomb/Int'l
Transactions
- Exercise/Conversion
Restricted Share Units
2022-02-27$24.35/sh−17,350$422,473→ 0 totalExercise: $24.35Exp: 2022-02-27→ Common Shares, No Par Value (0 underlying) - Exercise/Conversion
Common Shares, No Par Value
2022-02-27+17,350→ 127,988 total - Tax Payment
Common Shares, No Par Value
2022-02-26$24.35/sh−1,522$37,061→ 120,233 total - Tax Payment
Common Shares, No Par Value
2022-02-27$24.35/sh−6,233$151,774→ 121,755 total - Tax Payment
Common Shares, No Par Value
2022-02-27$24.35/sh−1,716$41,785→ 118,517 total - Award
Restricted Share Units
2022-02-27+17,350→ 0 totalExp: 2022-02-27→ Common Shares, No Par Value (17,350 underlying) - Sale
Common Shares, No Par Value
2022-03-01$23.82/sh−6,338$150,971→ 112,179 total
Footnotes (6)
- [F1]Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer.
- [F2]Each PSU converts into Common Shares on a one-for-one basis
- [F3]This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs.
- [F4]This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs").
- [F5]This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs.
- [F6]The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2021.
Documents
Issuer
Bausch Health Companies Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001749876
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 9:29 PM ET
- Size
- 16.7 KB